米国市場銘柄情報

BIOR ビオラ・セラピューティクス

銘柄追加

0.6420
-0.0134-2.04%

終値 05/01 16:00 ET

0.6500
+0.0080+1.25%

市場前 08:09 ET

2,303.74万時価総額-81直近PER

ビオラ・セラピューティクスに関するコメント

ログインコメントを投稿

Jaguar8

04/30 20:04

$ビオラ・セラピューティクス(BIOR.US)$
NEWS
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600

Trytosaveabit

04/08 20:05

News

$ビオラ・セラピューティクス(BIOR.US)$ Biora Therapeutics Announces New Patent Covering Its BioJet Liquid Jet Delivery Technology
Benzinga· 2 mins ago

Trytosaveabit

04/04 04:06

Update

$ビオラ・セラピューティクス(BIOR.US)$ Press Release: Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Dow Jones· 1 min ago

Trytosaveabit

03/27 04:19

Cool! Like! Now need some data release dates!

$ビオラ・セラピューティクス(BIOR.US)$ performance targets achieved in single-ascending dose (SAD) cohorts of BT-600 clinical trial
Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood
Remainder of BT-600 clinical trial progressing well and on schedule

joeyboulevard

03/12 05:56

$ビオラ・セラピューティクス(BIOR.US)$ up tomorrow with good news

Moomoo AI

03/11 20:10

The CFO of Biora Therapeutics, Eric d'Esparbes, expressed confidence in the company's progress towards optimizing its capital structure and developing its therapeutics programs. The recent transactions are seen as a strong indication of investors' continued confidence in Biora's programs.